Coronary Artery Disease Global Market Report 2024

Description

Coronary artery disease (CAD) is a medical condition affecting the coronary arteries, responsible for supplying oxygen-rich blood to the heart muscle. The disease occurs when these arteries become narrowed or obstructed due to the accumulation of plaque-a buildup of cholesterol, fat, calcium, and other substances.

Primary treatments for coronary artery disease encompass various approaches such as medication, surgical interventions, additional therapies, and other related strategies. Medications include pharmaceutical substances such as clopidogrel, atorvastatin, metoprolol, lisinopril, losartan, amlodipine, nitroglycerin, among others. Diagnosis involves medical procedures such as electrocardiogram (ECG), echocardiogram, stress tests, cardiac catheterization, heart CT scans, and other diagnostic methods. These medications and diagnostic procedures are made available through diverse distribution channels such as hospital pharmacies, retail pharmacies, online pharmacy platforms, and others. The utilization of these treatments and diagnostic measures extends to hospitals, specialty clinics, and other healthcare facilities.

The coronary artery disease market research report is one of a series of new reports from The Business Research Company that provides coronary artery disease market statistics, including coronary artery disease industry global market size, regional shares, competitors with a coronary artery disease market share, detailed coronary artery disease market segments, market trends and opportunities, and any further data you may need to thrive in the coronary artery disease industry. This coronary artery disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary artery disease market size has grown rapidly in recent years. It will grow from $26.3 billion in 2023 to $28.97 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The observed growth in the historic period can be attributed to several factors. These include the widespread prevalence of coronary artery disease, advancements in minimally invasive surgical techniques contributing to improved treatment options, the rise in sedentary lifestyles impacting cardiovascular health, an aging population leading to increased cases of coronary artery disease, and the evolution and advancement of pharmacological treatments providing better management and care for individuals affected by this condition.

The coronary artery disease market size is expected to see rapid growth in the next few years. It will grow to $42.65 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing impact of lifestyle-related factors on heart health, a heightened focus on telemedicine and remote monitoring for managing coronary artery disease, the expansion of interventional cardiology procedures for improved treatment outcomes, a shift towards value-based healthcare models emphasizing patient outcomes, and the ongoing development of innovative drug therapies for more effective management of the condition. Major trends expected in this forecast period encompass the development of gene therapies targeting heart-related conditions, the integration of artificial intelligence in diagnosing and managing coronary artery disease, a heightened focus on mental health aspects within coronary artery disease care, a rise in home-based healthcare services catering to cardiac patients, and the adoption of remote cardiac rehabilitation programs for enhanced patient recovery and management.

The growth of the coronary artery disease market is anticipated to be fueled by the increasing prevalence of coronary artery disease (CAD). This medical condition is characterized by the narrowing or blockage of coronary arteries, responsible for supplying blood to the heart muscle. Factors contributing to the rise in CAD cases include dietary changes, stress, sedentary lifestyle, obesity, and aging. Treatment modalities for coronary artery disease involve drug interventions such as clopidogrel, ticagrelor, warfarin, and heparin, along with procedural approaches such as coronary artery bypass grafting, angioplasty, and stenting. As per the Centers for Disease Control and Prevention's May 2023 report, coronary heart disease, the most common form of heart disease, claimed 375,476 lives in 2021, affecting approximately 5% of adults aged 20 and above. This prevalence is expected to drive the coronary artery disease market during the forecast period.

The growth trajectory of the coronary artery disease market is further propelled by the rising aging population. An aging population signifies a demographic shift characterized by an increasing proportion of elderly individuals within a society. The demographic trend contributes significantly to the expansion of the coronary artery disease market, given the higher susceptibility of older individuals to this condition. According to the World Health Organization's October 2022 projection, by 2030, one in six individuals globally will be 60 years old or older. During this period, the population aged 60 and over is expected to increase from 1 billion in 2020 to 1.4 billion. Looking ahead to 2050, the global population of individuals aged 60 and older is forecasted to double, reaching 2.1 billion. This demographic shift underlines the role of the rising aging population in propelling the coronary artery disease market.

Prominent companies within the coronary artery disease market are directing their efforts toward developing cutting-edge technologies, including AI-based blood tests. These tests leverage artificial intelligence (AI) algorithms for the analysis and interpretation of blood-related data. For instance, in February 2023, Cardio Diagnostics Holdings, a US-based company specializing in AI-based integrated genetic-epigenetic engines, introduced PrecisionCHD. This innovative blood test combines genetic and epigenetic analyses to enable early identification of coronary heart disease. With a sensitivity of over 75% for both men and women, PrecisionCHD employs a machine-learning model derived from the analysis of billions of genomic and epigenomic data points, incorporating epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.

Major players in the coronary artery disease market are concentrating on the development of groundbreaking products such as drug-coated balloon catheters. These medical devices are utilized in interventional cardiology procedures to address narrowed or blocked blood vessels, particularly in cases of coronary artery disease or peripheral artery disease. An example is Medtronic PLC, an Ireland-based medical device company, which launched Prevail DCB, the latest-generation drug-coated balloon catheter, in July 2021. Prevail DCB is employed in percutaneous coronary intervention (PCI) procedures to address the narrowing or obstruction of coronary arteries in individuals diagnosed with coronary artery disease (CAD). This emphasis on innovation underscores the commitment of major industry players to advancing technologies for enhanced coronary artery disease management.

In April 2023, Abbott Laboratories, a prominent US-based medical devices and healthcare company, completed the acquisition of Cardiovascular Systems Inc. for a total consideration of $890 million. This strategic acquisition is designed to enhance Abbott's capabilities in addressing vascular disease by integrating the innovative solutions developed and commercialized by Cardiovascular Systems Inc. The latter, based in the United States, is a medical device company with a focus on creating and bringing to market advanced treatments for peripheral and coronary artery disease. This move is indicative of Abbott's commitment to expanding its portfolio and strengthening its position in the medical devices sector, particularly in the field of cardiovascular health.

Major companies operating in the coronary artery disease market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum fur Herz- Kreislauf-Forschung (DZHK) e.V.

North America was the largest region in the coronary artery disease market in 2023. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary artery disease market includes revenues earned by entities by providing coronary angioplasty, coronary artery bypass and heart transplant services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Artery Disease Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary artery disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary artery disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coronary artery disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Treatment: Medication; Surgery; Additional Therapy; Other Treatments
2) By Diagnosis: Electrocardiogram; Echocardiogram; Stress Test; Cardiac Catheterization; Heart CT Scan; Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Channels
4) By End-User: Hospitals; Specialty Clinics; Other End-Users
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13610

1. Executive Summary

2. Coronary Artery Disease Market Characteristics

3. Coronary Artery Disease Market Trends And Strategies

4. Coronary Artery Disease Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Coronary Artery Disease Market Size and Growth

5.1. Global Coronary Artery Disease Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Coronary Artery Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Coronary Artery Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Coronary Artery Disease Market Segmentation

6.1. Global Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Medication
Surgery
Additional Therapy
Other Treatments
6.2. Global Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Electrocardiogram
Echocardiogram
Stress Test
Cardiac Catheterization
Heart CT Scan
Other Diagnosis
6.3. Global Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other Channels
6.4. Global Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Other End-Users

7. Coronary Artery Disease Market Regional And Country Analysis

7.1. Global Coronary Artery Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Coronary Artery Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Coronary Artery Disease Market

8.1. Asia-Pacific Coronary Artery Disease Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Coronary Artery Disease Market

9.1. China Coronary Artery Disease Market Overview
9.2. China Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Coronary Artery Disease Market

10.1. India Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Coronary Artery Disease Market

11.1. Japan Coronary Artery Disease Market Overview
11.2. Japan Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Coronary Artery Disease Market

12.1. Australia Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Coronary Artery Disease Market

13.1. Indonesia Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Coronary Artery Disease Market

14.1. South Korea Coronary Artery Disease Market Overview
14.2. South Korea Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Coronary Artery Disease Market

15.1. Western Europe Coronary Artery Disease Market Overview
15.2. Western Europe Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Coronary Artery Disease Market

16.1. UK Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Coronary Artery Disease Market

17.1. Germany Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Coronary Artery Disease Market

18.1. France Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Coronary Artery Disease Market

19.1. Italy Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Coronary Artery Disease Market

20.1. Spain Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Coronary Artery Disease Market

21.1. Eastern Europe Coronary Artery Disease Market Overview
21.2. Eastern Europe Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Coronary Artery Disease Market

22.1. Russia Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Coronary Artery Disease Market

23.1. North America Coronary Artery Disease Market Overview
23.2. North America Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Coronary Artery Disease Market

24.1. USA Coronary Artery Disease Market Overview
24.2. USA Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Coronary Artery Disease Market

25.1. Canada Coronary Artery Disease Market Overview
25.2. Canada Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Coronary Artery Disease Market

26.1. South America Coronary Artery Disease Market Overview
26.2. South America Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Coronary Artery Disease Market

27.1. Brazil Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Coronary Artery Disease Market

28.1. Middle East Coronary Artery Disease Market Overview
28.2. Middle East Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Coronary Artery Disease Market

29.1. Africa Coronary Artery Disease Market Overview
29.2. Africa Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Coronary Artery Disease Market Competitive Landscape And Company Profiles

30.1. Coronary Artery Disease Market Competitive Landscape
30.2. Coronary Artery Disease Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AbbVie Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bayer AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Coronary Artery Disease Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca plc
31.4. Abbott Laboratories
31.5. GlaxoSmithKline plc
31.6. Gilead Sciences Inc.
31.7. Amgen Inc.
31.8. Viatris Inc.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Aurobindo Pharma Ltd.
31.11. Hikma Pharmaceuticals plc
31.12. Amneal Pharmaceuticals Inc.
31.13. Chiesi Farmaceutici S.p.A.
31.14. Lupin Pharmaceuticals Inc.
31.15. Wockhardt Ltd.

32. Global Coronary Artery Disease Market Competitive Benchmarking

33. Global Coronary Artery Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Coronary Artery Disease Market

35. Coronary Artery Disease Market Future Outlook and Potential Analysis

35.1 Coronary Artery Disease Market In 2028 - Countries Offering Most New Opportunities
35.2 Coronary Artery Disease Market In 2028 - Segments Offering Most New Opportunities
35.3 Coronary Artery Disease Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer